PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
BACKGROUND: Due to its rarity, duodenal papillary carcinoma (DPC) is seldom studied as a unique disease and no specific molecular features or treatment guidelines are provided. METHODS: Whole‐exome sequencing was performed to gain new insights into the DPC mutation landscape and to identify potentia...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523678/ https://www.ncbi.nlm.nih.gov/pubmed/36178086 http://dx.doi.org/10.1002/ctm2.1062 |